SlideShare a Scribd company logo
Basic Cardiac Dysrhythmias
Atrial and Junctional Rhythms
Rev 2016
Atrial Fibrillation
Rate: Variable, Atrial Rate 400bpm or greater (immeasurable) Ventricular
Rate 60-100bpm considered “Controlled”, below 60bpm termed A. Fib
with Slow Ventricular Response, above 100 considered Rapid A. Fib
Regularity: Irregularly Irregular
P Wave Morphology and AV Ratio: No prominent P waves present. Fine
fibrillatory waves (f waves) visible as almost flat line.
PR Interval: Immeasurable
QRS Duration and Morphology: Less than 120ms (0.12seconds). Identical
Morphology
QT Interval: Less than ½ the preceding R-R Interval
Atrial Fibrillation
Causes: many different sites of both atria, and sites in
the pulmonary veins that are irritable, and firing
rapidly, and irregularly.
Causes of the irritable cells include: Hypoxia, Ischemia,
Infarction, Electrolyte disturbances Hypervolemia
(causes stretch of the atria), Cardiac Surgery (50% of
Valve surgery patients develop AF, approx. 25% of
CABG patients develop AF), Excessive adrenergic
stimulation (catecholamine surge from stress,
surgery), Cardiomyopathy, CHF, Pericarditis,
Alcohol Withdrawal, Hyperthyroidism.
Atrial Fibrillation
Concerns: Atrial Fibrillation is the most common
dysrhythmia.
Patients can live with permanent AF.
1) Rate control
2) Prevent Clot Formation
3) Loss of Cardiac Output form “Atrial Kick”
Initial Treatment of Atrial Fibrillation
Rate Control: Initial treatment is with β-adrenergic
blockers or Calcium Channel Blockers. These
medications the have negative chronotropic and/or
negative dromotropic properties (slow speed of
conduction through AV node) Amiodarone is not
recommended as a first line treatment due the drug’s
extensive side effect/adverse reaction profile.
Anticoagulation: If the underlying etiology cannot be
corrected, or the rhythm cannot be converted within
24 hours, anticoagulation is indicated to prevent
blood clot formation.
Conversion of Atrial fibrillation to
Sinus Rhythm
Ideally, treatment of atrial fibrillation includes
correcting the rhythm disturbance and conversion
to sinus rhythm. This is not always possible for all
patients.
Methods to achieve this goal include: Antiarrhythmic
Drugs: Propafenone, Flecainide, Sotalol,
Dofetilide, Amiodarone, Dronedarone
Cardioversion EP Procedures MAZE
Atrial Flutter
Atrial Flutter
Rate: Atrial Rate 250-400, Ventricular Rate Variable
Regularity: Atrial Regular, Ventricular-Variable
dependent on A:V
P Wave Morphology and AV Ratio: Fast “saw-tooth”
or “picket fence” Flutter waves (F waves) Present
and Uniform. AV Ratio can be fixed as 3:1, 4:1
etc. (and the Ventricular Rhythm is regular) or
variable (Variable Conduction Ratio).
PR Interval: Immeasurable
QRS Duration and Morphology: Less than 120ms
(0.12seconds). Identical Morphology
QT Interval: Less than ½ the preceding R-R Interval
Treatment: similar to Atrial fibrillation- responds
better to cardioversion
Premature Atrial Complexes (PACs)
By Definition, PACs are early beats that come from the Atria
PACs make the Ventricular Rhythm Irregular, they can occur
as occasional or frequent individual beats or in patterns
such as Bigeminy, or Trigeminy
PACs can be Unifocal or Multifocal (coming from multiple
areas of the atria, and having multiple P wave morphologies).
PACs
QRS Duration and Morphology: Less than 120ms
(0.12seconds) if conducted through the His-
Purkinje System in a normal fashion. If the QRS
following the P wave of a PAC is wider than the
other QRS Complexes, the impulse has depolarized
the heart in an aberrant fashion. (Those beats are
called PACs with aberrant conduction)
PACs indicate that an area, or areas of the atria are
irritated. PACs are often precursor beats to Atrial
Fibrillation and Atrial Flutter.
Treatment for “high-risk” groups.
Wandering Atrial Pacer
Rate: Usually between 60-100bpm, termed Multiple Atrial Tachycardia if
above 100bpm
Regularity: Regular or Irregular
P Wave Morphology and AV Ratio: At least 3 different P wave
Morphologies by definition. A:V ration 1:1.
PR Interval: Will Vary Depending on Location of Ectopic Atrial Sites, and
some may be less than 120ms(0.12seconds).
QRS Duration and Morphology: Less than 120ms (0.12seconds).
QT Interval: Less than ½ the preceding R-R Interval
WAP
In WAP, multiple sites, including the SA node, the
Atria and the AV node compete for pacing the heart.
It is a sign of increased autorhythmicity of the various
pacing sites of the heart.
Causes: Common causes include mitral or tricuspid
valve disease, chronic lung disease, digitalis
preparations or enhanced vagal tone.
Patients usually asymptomatic. Discontinue or
change dosage of any medications thought to
be the cause of the arrhythmia.
Junctional Escape Rhythms
Rate: 40-60bpm
Regularity: Regular
P Wave One of three morphologies as described on
previous slide
AV Ratio: Retrograde P waves before or after the
QRS complexes, or No visible P waves
PR Interval: PR Interval is less than 120ms (0.12 sec)
if P waves are prior to QRS complexes
QRS Duration and Morphology: Less than 120ms
(0.12seconds).
QT Interval: Less than ½ the preceding R-R Interval
Junctional Escape Rhythm
The AV junction is the second line of defense
in the hierarchy of pacemakers. evidence of
a junctional rhythm may be protective for a
patient with impaired SA node
autorhythmicity.
Common causes include damage to the SA
node from MI, or ischemia, calcification,
Valvular heart disease, and Myocarditis,
CHF and Digitalis Toxicity.
Accelerated Junctional and Junctional
Tachycardia Rhythms
Rate: Accelerated = 60-100 bpm Tachycardia=
greater than 100 bpm
P Wave Morphology: Same P wave morphologies as
Junctional Escape Rhythms
PR Interval: Short if Measurable
Accelerated Junctional Rhythm
Causes: Enhance Autorhythmicity of Junction
including Digitalis or Theophylline toxicity,
catecholamine surge from stress or stimulants,
or acid base imbalances.
Treatments: Treatment is based on removal of
cause, and control of heat rate. Meds that limit
the automaticity of the Junction include β-
Blockers, Ca Channel Blockers and
Amiodarone,
Premature Junctional Complexes
(PJCs)
By Definition, PJCs are early beats that originate
from the Junction
PJCs take on the same morphology as Junctional Escape
Rhythms, with either Retrograde P waves prior to or
after the QRS complexes, or No Visible P waves.
Supra-Ventricular Tachycardia (SVT)
Fast Rhythms:
First Discern if the Rhythm comes from the ventricle
(wide QRS complex), or from above the ventricle
(Narrow QRS complex).
Then Identify the specific origin of the Rhythm.
Treatment of SVTs
Serious signs and symptoms (hypotension,
acutely altered mental status, signs of shock,
ischemic chest discomfort, acute heart failure):
1. Immediate Synchronized Cardioversion
2. Consider adenosine (now also first line)
Stable without rate related CV compromise:
1.Attempt to visualize the origin of the SVT
by using vagal maneuvers or adenosine.
2. Slow the ventricular response using Ca
channel blockers or B-adrenergic blockers.
Synchronized Cardioversion
Goal: spontaneous depolarization of a “critical
mass” of cardiac cells to disrupt the erratic
tachycardia, with hope that the conduction
system will restore normal function.
Synchronized with the patient’s rhythm to
deliver the electrical current on the R wave to
prevent deterioration to less viable rhythm.
Painful: provide analgesia, and anxiolytics
Vagal Maneuvers
Bearing down
Coughing
Suctioning
Deep Held Breath
Digital Rectal Stimulation
Vomiting
Carotid Sinus Massage (Only advanced, insured
practitioners, after checking for bruits)
Adenosine
Used as a diagnostic tool to help identify
rhythm.
Adenosine
6mg IVP, “high and fast”
May repeat with 12 mg, q 1-2 min x 2
Predictable signs and symptoms: CP, palpitation,
LOC, SOB diaphoresis – please inform patient

More Related Content

What's hot

Narrow QRS Tachycardia
Narrow QRS TachycardiaNarrow QRS Tachycardia
Narrow QRS Tachycardia
Ramachandra Barik
 
Supraventricular tachyarrythmias
Supraventricular tachyarrythmiasSupraventricular tachyarrythmias
Supraventricular tachyarrythmias
Rawalpindi Medical College
 
cardiac arrhythmias
cardiac arrhythmiascardiac arrhythmias
cardiac arrhythmias
zarishfazil
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
Tachyarrhythmia
SMSRAZA
 
Approach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardiaApproach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardia
Praveen Nagula
 
Cardiac arrhythmia
Cardiac arrhythmiaCardiac arrhythmia
Cardiac arrhythmia
Mahesh Kumar
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
Rashad Siddiqi
 
CARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIASCARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIAS
PRATYUSH KANTI MISRA
 
Supraventricular tacchycardias
Supraventricular tacchycardias Supraventricular tacchycardias
Supraventricular tacchycardias
Rawalpindi Medical College
 
Narrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi rajuNarrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi raju
Tammiraju Iragavarapu
 
Atrial dysrhythmia
Atrial dysrhythmiaAtrial dysrhythmia
Atrial dysrhythmiaAhmad Thanin
 
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
SMSRAZA
 
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios SupplementalACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
Imhotep Virtual Medical School
 
Cardiac Arrhythmias
Cardiac ArrhythmiasCardiac Arrhythmias
Cardiac Arrhythmias
Kathiri Venkat
 
Als core ecg rhythm by dr vijaykumar silvaraja
Als core ecg rhythm by dr vijaykumar silvarajaAls core ecg rhythm by dr vijaykumar silvaraja
Als core ecg rhythm by dr vijaykumar silvaraja
VijayKumar Silvaraja
 

What's hot (20)

Narrow QRS Tachycardia
Narrow QRS TachycardiaNarrow QRS Tachycardia
Narrow QRS Tachycardia
 
Supraventricular tachyarrythmias
Supraventricular tachyarrythmiasSupraventricular tachyarrythmias
Supraventricular tachyarrythmias
 
cardiac arrhythmias
cardiac arrhythmiascardiac arrhythmias
cardiac arrhythmias
 
ECG - Narrow complex tachycardia
ECG - Narrow complex tachycardiaECG - Narrow complex tachycardia
ECG - Narrow complex tachycardia
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
Tachyarrhythmia
 
Approach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardiaApproach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardia
 
Cardiac arrhythmia
Cardiac arrhythmiaCardiac arrhythmia
Cardiac arrhythmia
 
Ecg 4
Ecg 4Ecg 4
Ecg 4
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 
Ecg rhythms charex
Ecg rhythms charexEcg rhythms charex
Ecg rhythms charex
 
CARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIASCARDIAC ARRHYTHMIAS
CARDIAC ARRHYTHMIAS
 
Supraventricular tacchycardias
Supraventricular tacchycardias Supraventricular tacchycardias
Supraventricular tacchycardias
 
Narrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi rajuNarrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi raju
 
Atrial dysrhythmia
Atrial dysrhythmiaAtrial dysrhythmia
Atrial dysrhythmia
 
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
 
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios SupplementalACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
ACLS CE -Part I of III -ECG STRIP INTERPRETATION w Case Scenarios Supplemental
 
Cardiac Arrhythmias
Cardiac ArrhythmiasCardiac Arrhythmias
Cardiac Arrhythmias
 
Als core ecg rhythm by dr vijaykumar silvaraja
Als core ecg rhythm by dr vijaykumar silvarajaAls core ecg rhythm by dr vijaykumar silvaraja
Als core ecg rhythm by dr vijaykumar silvaraja
 
Tachyarrhythmia's
Tachyarrhythmia'sTachyarrhythmia's
Tachyarrhythmia's
 
Arrhythmias July 09
Arrhythmias July 09Arrhythmias July 09
Arrhythmias July 09
 

Similar to Ecg dysrhythmias-ii

Ecg dysrhythmias-i
Ecg dysrhythmias-iEcg dysrhythmias-i
Ecg dysrhythmias-i
RawanMisk
 
PERIOPERATIVE ARRYTHMIAS
PERIOPERATIVE ARRYTHMIASPERIOPERATIVE ARRYTHMIAS
PERIOPERATIVE ARRYTHMIAS
ashishnair22
 
APPROACH TO NARROW COMPLEX TACHYCARDIA
APPROACH TO NARROW COMPLEX TACHYCARDIAAPPROACH TO NARROW COMPLEX TACHYCARDIA
APPROACH TO NARROW COMPLEX TACHYCARDIA
PDT DM CARDIOLOGY
 
Brady and tachyarrythmias diagnosis and management
Brady and tachyarrythmias   diagnosis and managementBrady and tachyarrythmias   diagnosis and management
Brady and tachyarrythmias diagnosis and management
Alphonse Aswin
 
Approach to svt
Approach to svt Approach to svt
Approach to svt
Amir Mahmoud
 
Arrythmias and ek gs 1
Arrythmias and ek gs 1Arrythmias and ek gs 1
Arrythmias and ek gs 1Manish Mahajan
 
Approach to Bradycardia.pptx
Approach to Bradycardia.pptxApproach to Bradycardia.pptx
Approach to Bradycardia.pptx
Hermonhaile2
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Dr. Pravin Wahane
 
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptxEdited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
Muhammad Habib
 
ELectrophysiology basics part4
ELectrophysiology basics part4ELectrophysiology basics part4
ELectrophysiology basics part4
salah_atta
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
EhealthMoHS
 
ECG Monitoring (Basic of ECG)
ECG  Monitoring  (Basic of ECG)ECG  Monitoring  (Basic of ECG)
ECG Monitoring (Basic of ECG)
Gajan Gaja
 
Management of peri arrest arrhythmias
Management of peri arrest arrhythmiasManagement of peri arrest arrhythmias
Management of peri arrest arrhythmiasMaher Assaf
 
3a atrial rhythms
3a atrial rhythms3a atrial rhythms
3a atrial rhythmsTeleClinEd
 
Atrial Rhythms - BMH/Tele
Atrial Rhythms - BMH/TeleAtrial Rhythms - BMH/Tele
Atrial Rhythms - BMH/TeleTeleClinEd
 
Supra ventri cular arrhythmia 2021
Supra ventri cular arrhythmia  2021Supra ventri cular arrhythmia  2021
Supra ventri cular arrhythmia 2021
rajasthan govt
 
Arrhythmia
ArrhythmiaArrhythmia
Arrhythmia
kthdiazg74
 
Arrhythmias general
Arrhythmias generalArrhythmias general
Arrhythmias general
Adarsh
 
SVT-Alogarythm
SVT-AlogarythmSVT-Alogarythm
SVT-Alogarythm
Ramachandra Barik
 

Similar to Ecg dysrhythmias-ii (20)

Ecg dysrhythmias-i
Ecg dysrhythmias-iEcg dysrhythmias-i
Ecg dysrhythmias-i
 
PERIOPERATIVE ARRYTHMIAS
PERIOPERATIVE ARRYTHMIASPERIOPERATIVE ARRYTHMIAS
PERIOPERATIVE ARRYTHMIAS
 
ECG Rhythm Abnormalities
ECG Rhythm AbnormalitiesECG Rhythm Abnormalities
ECG Rhythm Abnormalities
 
APPROACH TO NARROW COMPLEX TACHYCARDIA
APPROACH TO NARROW COMPLEX TACHYCARDIAAPPROACH TO NARROW COMPLEX TACHYCARDIA
APPROACH TO NARROW COMPLEX TACHYCARDIA
 
Brady and tachyarrythmias diagnosis and management
Brady and tachyarrythmias   diagnosis and managementBrady and tachyarrythmias   diagnosis and management
Brady and tachyarrythmias diagnosis and management
 
Approach to svt
Approach to svt Approach to svt
Approach to svt
 
Arrythmias and ek gs 1
Arrythmias and ek gs 1Arrythmias and ek gs 1
Arrythmias and ek gs 1
 
Approach to Bradycardia.pptx
Approach to Bradycardia.pptxApproach to Bradycardia.pptx
Approach to Bradycardia.pptx
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy
 
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptxEdited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
Edited_-_ECG_Interpretation_and_Arrhythmia_Recognition_-_Azeren.pptx
 
ELectrophysiology basics part4
ELectrophysiology basics part4ELectrophysiology basics part4
ELectrophysiology basics part4
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
 
ECG Monitoring (Basic of ECG)
ECG  Monitoring  (Basic of ECG)ECG  Monitoring  (Basic of ECG)
ECG Monitoring (Basic of ECG)
 
Management of peri arrest arrhythmias
Management of peri arrest arrhythmiasManagement of peri arrest arrhythmias
Management of peri arrest arrhythmias
 
3a atrial rhythms
3a atrial rhythms3a atrial rhythms
3a atrial rhythms
 
Atrial Rhythms - BMH/Tele
Atrial Rhythms - BMH/TeleAtrial Rhythms - BMH/Tele
Atrial Rhythms - BMH/Tele
 
Supra ventri cular arrhythmia 2021
Supra ventri cular arrhythmia  2021Supra ventri cular arrhythmia  2021
Supra ventri cular arrhythmia 2021
 
Arrhythmia
ArrhythmiaArrhythmia
Arrhythmia
 
Arrhythmias general
Arrhythmias generalArrhythmias general
Arrhythmias general
 
SVT-Alogarythm
SVT-AlogarythmSVT-Alogarythm
SVT-Alogarythm
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Ecg dysrhythmias-ii

  • 1. Basic Cardiac Dysrhythmias Atrial and Junctional Rhythms Rev 2016
  • 2. Atrial Fibrillation Rate: Variable, Atrial Rate 400bpm or greater (immeasurable) Ventricular Rate 60-100bpm considered “Controlled”, below 60bpm termed A. Fib with Slow Ventricular Response, above 100 considered Rapid A. Fib Regularity: Irregularly Irregular P Wave Morphology and AV Ratio: No prominent P waves present. Fine fibrillatory waves (f waves) visible as almost flat line. PR Interval: Immeasurable QRS Duration and Morphology: Less than 120ms (0.12seconds). Identical Morphology QT Interval: Less than ½ the preceding R-R Interval
  • 3. Atrial Fibrillation Causes: many different sites of both atria, and sites in the pulmonary veins that are irritable, and firing rapidly, and irregularly. Causes of the irritable cells include: Hypoxia, Ischemia, Infarction, Electrolyte disturbances Hypervolemia (causes stretch of the atria), Cardiac Surgery (50% of Valve surgery patients develop AF, approx. 25% of CABG patients develop AF), Excessive adrenergic stimulation (catecholamine surge from stress, surgery), Cardiomyopathy, CHF, Pericarditis, Alcohol Withdrawal, Hyperthyroidism.
  • 4. Atrial Fibrillation Concerns: Atrial Fibrillation is the most common dysrhythmia. Patients can live with permanent AF. 1) Rate control 2) Prevent Clot Formation 3) Loss of Cardiac Output form “Atrial Kick”
  • 5. Initial Treatment of Atrial Fibrillation Rate Control: Initial treatment is with β-adrenergic blockers or Calcium Channel Blockers. These medications the have negative chronotropic and/or negative dromotropic properties (slow speed of conduction through AV node) Amiodarone is not recommended as a first line treatment due the drug’s extensive side effect/adverse reaction profile. Anticoagulation: If the underlying etiology cannot be corrected, or the rhythm cannot be converted within 24 hours, anticoagulation is indicated to prevent blood clot formation.
  • 6. Conversion of Atrial fibrillation to Sinus Rhythm Ideally, treatment of atrial fibrillation includes correcting the rhythm disturbance and conversion to sinus rhythm. This is not always possible for all patients. Methods to achieve this goal include: Antiarrhythmic Drugs: Propafenone, Flecainide, Sotalol, Dofetilide, Amiodarone, Dronedarone Cardioversion EP Procedures MAZE
  • 8. Atrial Flutter Rate: Atrial Rate 250-400, Ventricular Rate Variable Regularity: Atrial Regular, Ventricular-Variable dependent on A:V P Wave Morphology and AV Ratio: Fast “saw-tooth” or “picket fence” Flutter waves (F waves) Present and Uniform. AV Ratio can be fixed as 3:1, 4:1 etc. (and the Ventricular Rhythm is regular) or variable (Variable Conduction Ratio). PR Interval: Immeasurable QRS Duration and Morphology: Less than 120ms (0.12seconds). Identical Morphology QT Interval: Less than ½ the preceding R-R Interval Treatment: similar to Atrial fibrillation- responds better to cardioversion
  • 9. Premature Atrial Complexes (PACs) By Definition, PACs are early beats that come from the Atria PACs make the Ventricular Rhythm Irregular, they can occur as occasional or frequent individual beats or in patterns such as Bigeminy, or Trigeminy PACs can be Unifocal or Multifocal (coming from multiple areas of the atria, and having multiple P wave morphologies).
  • 10. PACs QRS Duration and Morphology: Less than 120ms (0.12seconds) if conducted through the His- Purkinje System in a normal fashion. If the QRS following the P wave of a PAC is wider than the other QRS Complexes, the impulse has depolarized the heart in an aberrant fashion. (Those beats are called PACs with aberrant conduction) PACs indicate that an area, or areas of the atria are irritated. PACs are often precursor beats to Atrial Fibrillation and Atrial Flutter. Treatment for “high-risk” groups.
  • 11. Wandering Atrial Pacer Rate: Usually between 60-100bpm, termed Multiple Atrial Tachycardia if above 100bpm Regularity: Regular or Irregular P Wave Morphology and AV Ratio: At least 3 different P wave Morphologies by definition. A:V ration 1:1. PR Interval: Will Vary Depending on Location of Ectopic Atrial Sites, and some may be less than 120ms(0.12seconds). QRS Duration and Morphology: Less than 120ms (0.12seconds). QT Interval: Less than ½ the preceding R-R Interval
  • 12. WAP In WAP, multiple sites, including the SA node, the Atria and the AV node compete for pacing the heart. It is a sign of increased autorhythmicity of the various pacing sites of the heart. Causes: Common causes include mitral or tricuspid valve disease, chronic lung disease, digitalis preparations or enhanced vagal tone. Patients usually asymptomatic. Discontinue or change dosage of any medications thought to be the cause of the arrhythmia.
  • 13.
  • 14. Junctional Escape Rhythms Rate: 40-60bpm Regularity: Regular P Wave One of three morphologies as described on previous slide AV Ratio: Retrograde P waves before or after the QRS complexes, or No visible P waves PR Interval: PR Interval is less than 120ms (0.12 sec) if P waves are prior to QRS complexes QRS Duration and Morphology: Less than 120ms (0.12seconds). QT Interval: Less than ½ the preceding R-R Interval
  • 15. Junctional Escape Rhythm The AV junction is the second line of defense in the hierarchy of pacemakers. evidence of a junctional rhythm may be protective for a patient with impaired SA node autorhythmicity. Common causes include damage to the SA node from MI, or ischemia, calcification, Valvular heart disease, and Myocarditis, CHF and Digitalis Toxicity.
  • 16. Accelerated Junctional and Junctional Tachycardia Rhythms Rate: Accelerated = 60-100 bpm Tachycardia= greater than 100 bpm P Wave Morphology: Same P wave morphologies as Junctional Escape Rhythms PR Interval: Short if Measurable
  • 17. Accelerated Junctional Rhythm Causes: Enhance Autorhythmicity of Junction including Digitalis or Theophylline toxicity, catecholamine surge from stress or stimulants, or acid base imbalances. Treatments: Treatment is based on removal of cause, and control of heat rate. Meds that limit the automaticity of the Junction include β- Blockers, Ca Channel Blockers and Amiodarone,
  • 18. Premature Junctional Complexes (PJCs) By Definition, PJCs are early beats that originate from the Junction PJCs take on the same morphology as Junctional Escape Rhythms, with either Retrograde P waves prior to or after the QRS complexes, or No Visible P waves.
  • 19. Supra-Ventricular Tachycardia (SVT) Fast Rhythms: First Discern if the Rhythm comes from the ventricle (wide QRS complex), or from above the ventricle (Narrow QRS complex). Then Identify the specific origin of the Rhythm.
  • 20. Treatment of SVTs Serious signs and symptoms (hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, acute heart failure): 1. Immediate Synchronized Cardioversion 2. Consider adenosine (now also first line) Stable without rate related CV compromise: 1.Attempt to visualize the origin of the SVT by using vagal maneuvers or adenosine. 2. Slow the ventricular response using Ca channel blockers or B-adrenergic blockers.
  • 21. Synchronized Cardioversion Goal: spontaneous depolarization of a “critical mass” of cardiac cells to disrupt the erratic tachycardia, with hope that the conduction system will restore normal function. Synchronized with the patient’s rhythm to deliver the electrical current on the R wave to prevent deterioration to less viable rhythm. Painful: provide analgesia, and anxiolytics
  • 22. Vagal Maneuvers Bearing down Coughing Suctioning Deep Held Breath Digital Rectal Stimulation Vomiting Carotid Sinus Massage (Only advanced, insured practitioners, after checking for bruits)
  • 23. Adenosine Used as a diagnostic tool to help identify rhythm. Adenosine 6mg IVP, “high and fast” May repeat with 12 mg, q 1-2 min x 2 Predictable signs and symptoms: CP, palpitation, LOC, SOB diaphoresis – please inform patient

Editor's Notes

  1. Atrial fibrillation is a common dysthythmia with very distinctive attributes. Most predominant is the fact that atrial fibrillation is an irregularly irregular rhythm. In fact, if you see an irregularly irregular rhythm with narrow QRS complexes, you should think that it is a-fib until proven otherwise. You will also note that there is no evidence of organized atrial depolarization. That is, there are no discernible p-waves. Instead, there are small fibrillatory waves called f waves. A –fib is multiple sites in the atria firing rapidly and simultaneously. Once these impulses reach the AV node, only a few are allowed to depolarize the ventricle, otherwise the patients heart rate would be 400 plus beats per minute. Since ventricular depolarization is unaltered the QRS duration and QT intervals are normal.
  2. Common causes of atrial fibrillation include hypoxia, ischemia, electrolyte disturbances like hypokalemia and hypomagnesaemia, and hypervolemia. Any stress state can lead to a-fib, especially post-surgical catecholamine surge and drug withdrawal. It is often a presenting symptom of hyperthyroidism especially in older women.
  3. There are three primary concerns with atrial fibrillation; rate control, clot formation and the loss of cardiac output. The ventricular rate in response to a-fib is of particular concern, and reflects the condition of the AV node. Specifically, a-fib can result in fast, slow or normal ventricular rate, and this depends on how quickly the impulses travel through the AV node. A goal is to maintain the ventricular rate between 60 and 100 beats per minute. Clot formation is also a major concern. Because there is no organized electrical activity in the atria, there is also no organized contraction. As a result, blood pools in both the right and left atrial and begins to clot. Blood clots can be ejected from the atrial and into the pulmonary or peripheral circuits and cause serious injury. Blood begins to clot within 24-48 hours after the onset of atrial fibrillation. Therefore, patients who are in a-fib for longer than 24 hours are started on anticoagulant medications. Further, if attempts are going to be made to convert a patients rhythm from a-fib to sinus rhythm, an echocardiogram is performed to guarantee that there is no clot in the atria. The lack of organized atrial contraction also decreases cardiac output by up to 30%. Atrial contraction contributes significantly to filling of the ventricles just before contraction, the so-called atrial kick. With such a decrease in cardiac output, patients are at risk for decreased end-organ perfusion and limited ability to augment their cardiac performance during exercise or other activity.
  4. The management of atrial fibrillation is outlined here. Drugs that can slow the speed of conduction through the AV node have what is called negative dromotropic properties. Most medications that decrease the heart rate are also negative dromotropic drugs, and will decrease the ventricular response to atrial fibrillation in patients who have a-fibrillation with rapid ventricular response. Amiodarone is an antiarrhythmic medication with additional beta adrenergic blocking and multiple ion channel altering qualities. Unfortunately, amiodarone also has many serious adverse reactions which make it undesirable as a first tier treatment for atrial fibrillation. It is used when other medications are ineffective and/or once the individual patient risk for adverse reactions has been quantified. Heparin is often used as the anticoagulant until long-term anti-coagulants are at levels great enough to be therapeutic.
  5. Ideally, treatment of atrial fibrillation includes correcting the rhythm disturbance and conversion to sinus rhythm. This is not always possible for all patients.’ Patients with newly diagnosed atrial fibrillation may respond to antiarrhythmic medications and convert back into sinus rhythm. Cardioversion, and several types of electrophysiological procedures including the MAZE procedure are used to convert patients into more hemodynamically and hematologically stable rhythms like sinus rhythm. The MAZE procedure can also be performed surgically.
  6. Atrial flutter is identified by rapid atrial depolarization. This can be seen as so-called picket fence, or saw tooth p-waves occurring throughout the entire rhythm strip. The top rhythm strip is atrial flutter with a fixed A-V ratio. That means that the ventricular response to this rapid atrial rhythm is regular. Here we see the regular and very fast atrial depolarization at a rate of about 300 beats per minute. Also, we note the regular R-R interval. When both the atrial and ventricular rhythms are regular it is called a fixed AV ratio. Here there are 3 p-waves for every QRS complex, therefore this is called 3:1 A flutter. The bottom strip is A-flutter with a variable AV ratio. Although the atrial rate is regular and also very fast, the ventricular rhythm is irregular. This is called A-flutter with variable ventricular response, or variable conduction ratio.
  7. The atrial rate in a-flutter is usually between 250-400 beats per minute, and as discussed the ventricular rate can vary. Since ventricular depolarization and repolarization is un-affected, the QRS duration and QT interval should be normal. If they are not, then there are different pathophsiological mechanisms at play. The treatment for atrial flutter is very similar to the treatment of atrial fibrillation. Oftentimes cardioversion is used, and there are medications that seem to work better with a-flutter than a-fib, and vise-versa Slow ventricular response with B-adrenergic blockers, Ca channel blockers, amiodarone or digoxin.
  8. PACs are not a rhythm but interrupt an underlying rhythm. Therefore, it is important to identify the underlying rhythm first, and then identify where the early beats come from. To begin looking at this strip, I have circled the two early beats. After analyzing the rhythm, one can determine that it is in fact sinus rhythm. Next, we need to discern where the early beats come from. We know that they are early because they occur before the next predicted beat, marked here by the red arrow. They can come from the atria, the junction or the ventricles. We have good evidence that these beats come from the atria, because the first waveform is an upright p-wave followed by a nice an narrow QRS complex. That means that atrial depolarization occurred first and in a normal fashion, and the ventricular depolarization was also normal. Thus, upright p-waves and normal QRS durations help identify where these early beats come from. Pay attention to the terminology described on this slide. This strip is an example of sinus rhythm with unifocal atrial quadrigeminy.
  9. The same conditions that cause a-fibb and a-flutter cause PACs. In fact, PAC’s are a sign that there is an area or multiple areas of the atria that are irritable, thus indicating that the patient may be at risk for converting to a-fibb or flutter. Patients who are at high risk for developing a-fibb may require treatment of PACs, which involves correcting oxygenation, electrolyte and/or fluid balance etc., to keep them from converting to a more dangerous rhythm. PACs in patients without high-risk are usually benign. In fact, if you monitored your heart rhythm continuously, you would no doubt see PACs, especially after substantial caffeine intake.
  10. Wandering atrial pacer is not a common rhythm, but has some unique characteristics. In this rhythm, there are at least three sites between the SA node, the atria and the junction that take over pacing for the heart. This is evidenced by at least three different p-wave morphologies. This also provides a decent rationale for determining that there uniform and upright p-waves before every QRS complex as one of the first few steps in rhythm analysis.
  11. Clarification of the definition of wandering atrial pacer and common causes are listed here. Please take a moment to review.
  12. Rhythms and beats that come from the junction of the AV node and Bundle of His take on one of three different morphologies. In this top strip, this junctional rhythm come from high in the junction and therefore depolarizes the atria first, and then the ventricle. Because this impulse comes from the AV node, depolarization of the atria occurs in a retrograde fashion, meaning from the bottom up as opposed to the top down. This results in a retrograde, or upside-down p-wave in front of a QRS complex. Junctional rhythms that originate from the middle of the junction depolarize the atria and ventricles at the same time, thus there is no visible p-wave. A key to differentiating mid-junctional rhythms from atrial-fibrillation is that junctional rhythms are always regular, where a-fibb is always irregularly irregular. Junctional rhythms that originate from low in the junction depolarize the ventricle first, and then the atria. This results in a QRS complex followed by a retrograde p-wave. Depolarization and repolarization of the ventricles is not affected, thus the QRS duration and QT intervals should be normal. You will be asked to identify a rhythm or beat that comes from the junction based on one of these three morphologies, but will not be held to determine where in the junction the beat originates.
  13. The three rhythms on the previous slide are all junction escape rhythms. That means that the AV node or surrounding tissue has taken over as the pacemaker of the heart. This is most often due to failure of the SA node. Junctional escape rhythms are slow, and regular, and take on one of the previously described morphologies. If the PR interval is measurable, it will be less than 120 milliseconds.
  14. A junctional escape rhythm is evidence of healthy AV node function in response to impaired or absent SA node firing. Common causes are listed here. Please take a moment to review this slide. Treatments: Treatment of all bradycardias is guided by symptoms. Asymptomatic junctional escape rhythms are not treated. Medications that block parasympathetic tone may not be as effective. Pacing or the use of Dopamine or Epinephrine drips may be indicated.
  15. If a junctional escape rhythm exceeds 60 beats per minute it is called accelerated junctional rhythm, and if it exceeds 100 beats per minute is called junctional tachycardia. Regarding this strip, we have evidence that this fast rhythm comes from the junction because of the retrograde p-waves in front of each QRS complex.
  16. If this rhythm has unwanted hemodynamic consequences, the treatment entails slowing the rate of impulse formation by administering beta blockers, calcium channel blockers or amiodarone. Accelerated junctional rhythm is often self-limiting.
  17. This sinus bradycardia is interrupted by two early beats, which are circled. When there are premature or early beats, it is important to determine their origin. These early beats come from the junction, as we have evidence of a retrograde p-wave that occurs after each nice and narrow QRS complex. This rhythm strip would be called sinus bradycardia with unifocal junctional trigeminy.
  18. Supraventricular tachycardia is a general term for fast rhythms that originate from above the ventricle. Because the rhythm is so fast, we cannot determine which rhythm it actually is. Instead, we can only determine that it is fast and comes from above the ventricle. Anytime you come across a fast rhythm, you should determine if the rhythms come from the ventricle, or comes from above the ventricle. We can determine this primarily by looking at the QRS duration. In general, SVTs have a narrow QRS that is less than 120 milliseconds , and rhythms that come from the ventricle have a QRS duration greater than 120 milliseconds. Once you have determined that it is a SVT, you will want to determine the area of impulse generation and provide a rhythm-specific treatment.
  19. If a patient exhibiting SVT has serious signs and symptoms, two treatments are recommended: synchronized cardioversion or adenosine. If the patient does not have serious signs and symptoms then attempts are made to slow the rhythm and determine the origin of the SVT. A definitive rhythm-specific treatment can then be developed. Vagal maneuvers alone are successful in approximately 25% of all SVTs. The first line drug for most stable regular narrow complex tachycardia is Adenosine. This medication slows the heart rate and is employed as both a therapeutic and diagnostic maneuver. Adenosine is not recommended for sinus tachycardia and is contraindicated in drug induced tachycardia and second or third degree heart block. Beta blockers or ca channel blockers are administered to slow the ventricular response.
  20. When an SVT results in serious signs and/or symptoms, synchronized cardioversion is indicated. This is a procedure performed with a defibrillator that aims to disrupts the erratic and hemodynamlically unstable rhythm in hopes that a more normal or manageable rhythm is restored. The goal of defibrillation is to cause the spontaneous depolarization of the majority of the cells in the heart at the same time. This involves sending a large amount of energy through the patients chest, which can be extremely painful and anxiety producing. Synchronized cardioversion is similar to defibrillation, but the two procedures differ in one important way. With synchronized cardioversion, the patient rhythm is taken into consideration. In fact, the device will start to detect and mark the patients QRS complexes and deliver the large amount of energy right on the R wave. This is the best place to try to synchronize the depolarization of a critical mass of cardiac cells, because many of the ventricular cells are already depolarized. Defibrillation is only use in patients who do not have a pulse, and does not take into account the patients underlying rhythm. These nuances will be revisited when defibrillation is discussed.
  21. If a patient with an SVT does not have serious signs and symptoms, non-pharmacological interventions may help stimulate the parasympathetic nervous system. Doing so will slow down the rate of the SA and AV nodes, and slow down the rate of impulse conduction through the AV node. There are several so-called vagal maneuvers that may cause a decrease in ventricular response to an SVT. The most commonly practiced vagal maneuvers are listed. Carotid Sinus massage is sometimes still used by physicians or advanced practitioners but comes with a significant stroke risk especially if a practitioner is unsure of existent plaque in the carotid arteries. Vagal maneuvers alone are successful in approximately 25% of all SVTs. When vagal maneuvers are performed successfully, the ventricular rate slows enough to detect the underlying atrial activity to see if the rhythm is sinus tachycardia, atrial flutter, junctional tachycardia etc. The appropriate rhythm-specific treatment may then be initiated.
  22. The first line drug for most stable regular narrow complex tachycardia is Adenosine. This medication slows the heart rate and is employed as both a therapeutic and diagnostic maneuver. Adenosine is not recommended for sinus tachycardia and is contraindicated in drug induced tachycardia and second or third degree heart block. Adenosine has a very short half life and must be given as a rapid IV push (over 1-3 seconds). The medication must be followed immediately with a bolus of 20ml of saline and elevation of the peripheral IV extremity. Adenosine stops ventricular activity for approximately 3-6 seconds. The patient may experience transient side effects including flushing, chest pain, or tightness, brief periods of asystole, bradycardia, or ventricular ectopy. Informing the patient of potential side effects is essential. Stopping the ventricular activity and allowing the heart to restart will enable you to determine the atrial activity, pinpointing the etiology of the SVT. The administration of Adenosine may be therapeutic, result in termination of SVT .